Please assess the completion status of the following clinical trial:

Trial Title: Liberal Versus Restrictive Transfusion During Symptomatic Moderate Anemia After Hip Arthroplasty

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age \> 18 and able to give consent~* Hip arthroplasty or hip revision arthroplasty~* Haemoglobin \> 4.8 mmol/L and \< 6.0 mmol/L on the first postoperative day~* Dizziness score ≥ 2.~Exclusion Criteria:~* Large ongoing bleeding~* Has already received RBC during the current admission~* New onset of cardiac arrhythmia suspected to be related to anemia~* Severe ischemic heart disease~* Renal failure with dialyses or oligouria / anuria.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- RBC transfusion (Type: ACTIVE_COMPARATOR): Administration of up to 2 RBC units on the first postoperative day.~(1 unit at a time followed by evaluation of the primary outcome measure)
- Restrictive: Colloid infusion (Type: PLACEBO_COMPARATOR): Infusion of up to 2 x 280 ml colloid (6% Hydroxyethyl Starch 130/0.4 in 0.9% Sodium Chloride). 280 ml at a time. Evaluation of primary outcome after each intervention.

Based on this trial design, predict the completion outcome and termination type (if applicable).